Scinai Immunotherapeutics Ltd Cash Flow Quality Index
Scinai Immunotherapeutics Ltd cash flow quality index. Scinai Immunotherapeutics Ltd (SCNI) has a Cash Flow Quality Index of -0.41x as of March 2026. Operating cash flow of $-1.45 Million is below net income of $3.57 Million, suggesting accrual-heavy earnings not yet converted to cash. See SCNI free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Scinai Immunotherapeutics Ltd (2024–2024)
Cash flow quality index of Scinai Immunotherapeutics Ltd from 2024 to 2024. Historical Cash Flow Quality Index for Scinai Immunotherapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Scinai Immunotherapeutics Ltd (SCNI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Scinai Immunotherapeutics Ltd Cash Flow Quality Index by Year (2024–2024)
Scinai Immunotherapeutics Ltd cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Scinai Immunotherapeutics Ltd. For the full cash flow conversion analysis, see SCNI cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | $-6.33 Million | $4.80 Million | — |